Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
Apply
NovoTTF-200T & Gemcitabine, Nab-Paclitaxel
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step